VaxCare, an industry leader in vaccine management solutions, presented the results of its recent study at the 2024 National Immunization Conference (NIC). The study—which involved sending text messages to more than 40,000 patients—confirmed the effectiveness of timely reminders in increasing vaccination rates among school-aged children.
ATLANTA, Sept. 19, 2024 /PRNewswire-PRWeb/ -- Hosted by the Centers for Disease Control and Prevention (CDC), the 2024 NIC brought together more than 1,500 subject matter experts and immunization contributors from the public and private sectors to share the latest information on vaccine-preventable diseases.
In addition to the scheduled sessions of the three-day event—the first since 2018—the agenda for each day also included a dedicated poster session to facilitate additional communication of the science, technology and services aimed at improving health in our communities. VaxCare applied and was accepted to share the results of its study on the effectiveness of text message reminders in increasing vaccination rates among school-aged children during the back-to-school season.
VaxCare's poster session was presented by Dr. Ruth Carrico, a family nurse practitioner based in Louisville, KY and an adjunct professor with the University of Louisville School Medicine, Division of Infectious Diseases.
"I was thrilled to be available to share the results of VaxCare's study at this year's NIC," said Ruth Carrico, PhD DNP APRN. "The conference provided a fantastic opportunity to share the great work and encouraging results we're seeing with our public health colleagues and industry representatives."
Data for this study was collected from a subset of practices using VaxCare's dedicated end-to-end vaccine management platform. Clinical sites leverage this platform to automate most of their vaccination workflow, from vaccine ordering and management to medical claims and billing. Utilizing de-identified information collected from May 31–Aug. 31, 2022, as part of VaxCare's "Vax-to-School" campaign—independently reviewed by the University of Louisville Institutional Review Board to ensure a rigorous ethical standard—the presentation provided attendees with an overview of the methodology, scope and detail of the analysis and a glimpse into the VaxCare platform.
The study, "Increasing back-to-school vaccination uptake via a large vaccine-centric ecosystem," analyzed data from 199,734 patients across 1,101 participating clinics, comparing vaccination rates between those who received text message reminders (40,018 patients) and those who did not. Results indicate that those receiving a reminder showed a substantial increase in vaccination rates, particularly for non-flu, non-COVID vaccines, highlighting the effectiveness of direct communication in boosting public health efforts.
Key Findings
- The group that received text messages saw an 18%+ increase in vaccination rates compared to the control group.
- Vaccine administration was higher among all ages that received text messages, with significant differences among children aged 11-12 years and ≥13 years of age.
- The greatest relative increase recorded during the study was for the Meningococcal B (MenB) vaccine, which was 64%+ compared to the control group.
- Notable increases were also recorded for the Measles-Mumps-Rubella (MMR) vaccine, which was 36%+, and the Human papillomavirus-9 (HPV) vaccine, which was 17%.
To learn more about how VaxCare's platform provides a comprehensive vaccination solution for practices nationwide, visit www.vaxcare.com/nic.
About VaxCare
Founded in 2008, VaxCare has been dedicated to improving the vaccination process for healthcare providers and their patients for more than 15 years. The point-of-care platform integrates the entire vaccine process into one simple touchpoint— working with clinics of all sizes to make vaccinating easy, efficient, and cost-free.
With over 17,000 partnered physicians and providers and 5,000 clinics across 40+ states, VaxCare's platform simplifies the management, administration and billing of more than four million vaccines annually.
Media Contact
Joe Loveless, VaxCare, 1 (888) 829-8550, [email protected], https://www.vaxcare.com/
SOURCE VaxCare
Share this article